ILMN

Illumina, Inc. develops and manufactures advanced sequencing and genomic analysis technologies. The company offers a range of products, including sequencing instruments, reagents, and software, primarily for applications in genomics, clinical research, and diagnostics. Illumina generates revenue through the sale of these products and associated financing solutions, such as leasing and reagent rental programs, which make its technology more accessible to customers. Its customer base includes academic institutions, healthcare providers, and research organizations across various global markets.